OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 50 filers reported holding OCUPHIRE PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,125 | -22.8% | 52,873 | 0.0% | 0.00% | – |
| Q2 2023 | $229,469 | -1.6% | 52,873 | -15.0% | 0.00% | – |
| Q1 2023 | $233,149 | -46.9% | 62,173 | -50.0% | 0.00% | – |
| Q4 2022 | $438,942 | +251.2% | 124,346 | +100.0% | 0.00% | – |
| Q3 2022 | $125,000 | +5.0% | 62,173 | 0.0% | 0.00% | – |
| Q2 2022 | $119,000 | -40.8% | 62,173 | 0.0% | 0.00% | – |
| Q1 2022 | $201,000 | -29.2% | 62,173 | -18.4% | 0.00% | – |
| Q4 2021 | $284,000 | +268.8% | 76,173 | +408.7% | 0.00% | – |
| Q3 2021 | $77,000 | -73.3% | 14,973 | -72.6% | 0.00% | – |
| Q2 2021 | $288,000 | – | 54,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 320,332 | $641,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 540,348 | $1,086,000 | 0.06% |
| Eidelman Virant Capital | 25,000 | $51,000 | 0.04% |
| Diametric Capital, LP | 24,548 | $49,000 | 0.02% |
| MAI Capital Management | 356,948 | $717,000 | 0.01% |
| Bedel Financial Consulting, Inc. | 15,000 | $31,000 | 0.01% |
| Warberg Asset Management LLC | 21,000 | $42,000 | 0.01% |
| Cornerstone Capital, Inc. | 13,857 | $28,000 | 0.00% |
| Stokes Family Office, LLC | 12,120 | $24,000 | 0.00% |
| CarsonAllaria Wealth Management, Ltd. | 1,000 | $2,000 | 0.00% |